Abstract
Aerosolised salbutamol does not improve clinical outcomes in patients with acute lung injury.
Level of evidence: 1B (Individual RCT with a wide confidence interval)
References
1.
Perkins
GD
,
Gates
S
,
Lamb
SE
Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome . Published online on 9 May 2011. Trials 12:113 .